Univest
Univest
  • Markets

NSE files IPO DRHP: NIACL rises 26% in 6 sessions, IFCI gains 7% a day after profit booking

  • June 19, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
NSE files IPO DRHP

NIACL Rs 196.12 (+9.77%) on 19 Jun 2026; day high Rs 198.50. 6-session rally ~28% from Rs 152.80. NSE IPO DRHP filed: OFS 14.89 Cr shares, ~Rs 5 lakh Cr valuation. IFCI Rs 86.85.

The National Stock Exchange of India (NSE) filed its Draft Red Herring Prospectus (DRHP) with SEBI on the night of June 18, 2026, for what is set to become India’s largest-ever initial public offering, with an estimated size of approximately Rs 30,000 crore at a valuation of approximately Rs 5 lakh crore. The NSE IPO is a pure Offer for Sale (OFS) of up to 14.89 crore equity shares (face value Re 1 each), representing approximately 6% of NSE’s paid-up capital. The filing triggered a sharp rally in listed stocks linked to NSE: shares of The New India Assurance Company Limited (NIACL), a direct selling shareholder in the NSE IPO OFS, have now risen approximately 28% over the past 6 sessions from Rs 152.80 (June 12 close) to Rs 196.12 on June 19, with today’s session alone contributing a gain of 9.77% as the stock hit a day high of Rs 198.50. Meanwhile, IFCI Limited, which has indirect NSE exposure through its 52.86% stake in Stock Holding Corporation of India Limited (SHCIL), is rebounding approximately 7% at its intraday high of Rs 87.98 on June 19, a day after the stock fell approximately 10% on June 18 due to profit booking following its 102% surge from the March 2026 low.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • NSE IPO DRHP Filing and Linked Stock Movements
  • NSE IPO DRHP: Why This Is India’s Most Consequential Market Filing in Years
  • NIACL: Why a Direct NSE Selling Shareholder Commands a Value Premium
    • 1. The NIACL-NSE Connection
    • 2. The 6-Session NIACL Rally: Session by Session
  • IFCI: The NSE IPO Proxy That Fell on the Very Day of Filing
  • Conclusion
    • What is the NSE IPO DRHP filing and why is it significant?
    • Why is NIACL share price rising after the NSE IPO DRHP filing?
    • Who are the selling shareholders in the NSE IPO OFS?
    • What is IFCI’s connection to NSE and why did it rally then fall?
    • What is NIACL’s 6-session rally timeline?
    • What are NIACL’s fundamentals and 52-week range?
    • What other stocks rallied on the NSE IPO DRHP filing?
    • Is now a good time to buy NIACL or IFCI based on the NSE IPO?

NSE IPO DRHP Filing and Linked Stock Movements

NSE IPO DRHP – Key Data Detail
NSE IPO DRHP Filing Night of June 18, 2026; filed with SEBI
IPO Type Pure Offer for Sale (OFS) – no fresh issue
OFS Size Up to 14.89 crore equity shares (face value Re 1)
OFS Stake ~6% of NSE paid-up capital
Estimated IPO Size ~Rs 30,000 crore at implied valuation ~Rs 5 lakh crore
If listed, would be India’s largest-ever IPO (eclipses LIC’s Rs 21,008 Cr in 2022)
NIACL (NSE: NIACL) Rs 196.12 (+9.77%) | Day High Rs 198.50 | Prev Close Rs 178.67
NIACL 6-Session Rally Rs 152.80 (Jun 12) to Rs 196.12 (Jun 19) = ~+28%; “26%” headline figure
NIACL 52W High / Low Rs 214.74 / Rs 116.97 | Market Cap ~Rs 29,444 crore
NIACL NSE Connection Direct selling shareholder in NSE IPO OFS
IFCI (NSE: IFCI) Rs 86.85 (+5.52%) | Day High Rs 87.98 (~+7%) | Prev Close Rs 82.31
IFCI NSE Connection (Direct) Holds 34.32 lakh NSE shares (participating in OFS)
IFCI NSE Connection (Indirect) 52.86% stake in SHCIL (SHCIL holds 4.44% of NSE; selling 10.89M shares via OFS)
IFCI 52W High / Low Rs 95.75 (Jun 17, 2026) / Rs 46.23 (Dec 18, 2025) | Rally from low: +107%
IFCI June 18 Profit Booking Fell ~10% to Rs 82.31 (closed) from 52W high; today rebounding

Track NSE IPO Proxy Stocks NIACL and IFCI Live on Univest Research

When Univest analysts track NSE IPO value-unlock stocks, investors position ahead of the listing.

Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks on Univest

See the Stocks →

NSE IPO DRHP: Why This Is India’s Most Consequential Market Filing in Years

The NSE IPO DRHP filed with SEBI on the night of June 18, 2026 is one of the most significant capital market events in Indian financial history. NSE is not just India’s largest stock exchange; it operates the Nifty 50, which is the primary benchmark for trillions of rupees in passive investments, pension funds and derivatives. Its listing would be the first time a major Indian stock exchange has been publicly traded, allowing retail investors to directly own a stake in the infrastructure that powers Indian equity markets. The NSE IPO is also a pure OFS with no fresh capital raised, meaning all proceeds go to the selling shareholders, including NIACL, which has been waiting over a decade for this liquidity event.

Track NIACL, IFCI and the full NSE IPO ecosystem live on the Univest Screener

NIACL: Why a Direct NSE Selling Shareholder Commands a Value Premium

1. The NIACL-NSE Connection

The New India Assurance Company Limited is a PSU general insurer under the Ministry of Finance. As a direct selling shareholder in the NSE IPO OFS, NIACL will sell a portion of its NSE equity holdings at the IPO price, generating a direct, one-time gain that will flow through to NIACL’s financials in the fiscal year the IPO is completed. Unlike IFCI’s indirect exposure through SHCIL, NIACL’s relationship with the NSE IPO is straightforward: the higher the NSE IPO price, the greater the realised gain for NIACL. This directness is why NIACL has outperformed all other NSE proxy stocks in the 6-session rally.

2. The 6-Session NIACL Rally: Session by Session

The NIACL 6-session rally from Rs 152.80 (June 12 close) to Rs 196.12 (June 19) was driven by a progression of news: NSE DRHP filing expectations intensified from June 12 on media reports that the filing was days away; volumes surged progressively through June 15-17; and on June 18, when the DRHP was actually filed, NIACL surged to an intraday high of Rs 188.50 (+14.24%) before closing at Rs 178.67 as some profit-booking emerged. On June 19, fresh buying resumed, taking NIACL to a day high of Rs 198.50 (+11.1% from the June 18 close). The cumulative 6-session gain from Rs 152.80 to Rs 196.12 is approximately 28%.

IFCI: The NSE IPO Proxy That Fell on the Very Day of Filing

The IFCI story around the NSE IPO is a classic example of the “buy the rumour, sell the news” dynamic. IFCI surged 102% from its March 2026 low of Rs 47.40 to a 52-week high of Rs 95.75-95.80 on June 17 on anticipation of the NSE DRHP filing. On June 18, the day of the actual filing, IFCI fell approximately 10% to close at Rs 82.31, as traders who had bought the rumour locked in gains. Today (June 19), with the profit-booking pressure easing, IFCI is recovering: the stock has hit a day high of Rs 87.98, representing approximately 7% upside from the June 18 close. At the current price of Rs 86.85, IFCI is approximately 9.3% below its 52-week high of Rs 95.75 and 83.3% above its 52-week low of Rs 46.23.

Download the Univest iOS App or Univest Android App to track NIACL, IFCI and the NSE IPO theme in real time on Univest.

Conclusion

NSE filed its DRHP with SEBI on June 18, 2026 for a pure OFS of 14.89 crore shares at an implied valuation of approximately Rs 5 lakh crore, making it the largest-ever Indian IPO if it proceeds at these terms. NIACL, a direct selling shareholder, has rallied approximately 28% over 6 sessions from Rs 152.80 (June 12) to Rs 196.12 (June 19). IFCI, with indirect NSE exposure through SHCIL, surged 102% from its March low before falling 10% on June 18 on profit booking; today it rebounds 7% at the day high of Rs 87.98. Consult a SEBI-registered financial advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What is the NSE IPO DRHP filing and why is it significant?

Ans. The National Stock Exchange of India (NSE) filed its Draft Red Herring Prospectus (DRHP) with SEBI on the night of June 18, 2026, for its long-awaited Initial Public Offering. The NSE IPO is a pure Offer for Sale of up to 14.89 crore equity shares (face value Re 1) representing approximately 6% of NSE’s paid-up capital, at an estimated size of Rs 30,000 crore and an implied valuation of approximately Rs 5 lakh crore. If listed at this valuation, the NSE IPO would be India’s largest-ever public issue, eclipsing LIC’s Rs 21,008 crore IPO of 2022. As of March 31, 2026, NSE is India’s largest stock exchange by cash market turnover and ranks third globally by number of trades in cash equities.

Why is NIACL share price rising after the NSE IPO DRHP filing?

Ans. NIACL (The New India Assurance Company Limited) share price is rising because NIACL is a direct selling shareholder in the NSE IPO OFS. This means NIACL holds NSE shares which it will partially monetise by selling them through the NSE IPO at the IPO price. When NSE is valued at approximately Rs 5 lakh crore in the DRHP, NIACL’s NSE shareholding becomes valued at a clearly stated market price for the first time, creating a tangible value unlock. NIACL has risen approximately 28% over 6 sessions from Rs 152.80 on June 12 to Rs 196.12 on June 19, including a 14.24% intraday surge to Rs 188.50 on June 18 when the DRHP was actually filed.

Who are the selling shareholders in the NSE IPO OFS?

Ans. The NSE IPO is a pure OFS with ten selling shareholders: SBI (State Bank of India), MS Strategic (Mauritius) Limited, Canada Pension Plan Investment Board, Aranda Investments (Mauritius) Pte Limited, Bank of Baroda (BOB), Stock Holding Corporation of India Limited (SHCIL), GIC Re (General Insurance Corporation of India), The New India Assurance Company Limited (NIACL), National Insurance Limited, and United India Insurance Company Limited. Notably, LIC, the largest NSE shareholder with 10.72% (26.52 crore shares), is not a selling shareholder in the OFS but benefited from the NSE IPO news, with LIC shares rising 4.71% to Rs 437.85 on June 18.

What is IFCI’s connection to NSE and why did it rally then fall?

Ans. IFCI Limited has two layers of NSE exposure. First, IFCI holds 34.32 lakh equity shares in NSE directly, as per the DRHP. Second, IFCI holds 52.86% equity in Stock Holding Corporation of India (SHCIL), which itself holds 4.44% (approximately 110 million shares) of NSE and is participating in the OFS by selling 10.89 million shares. This dual exposure made IFCI a popular proxy trade for the NSE IPO theme: IFCI surged 102% from its March 2026 low of Rs 47.40 to a 52-week high of Rs 95.75-95.80 on June 17. On June 18, after the DRHP was actually filed, IFCI fell approximately 10% as traders booked profits. Today (June 19), IFCI is rebounding 7% at the day high of Rs 87.98.

What is NIACL’s 6-session rally timeline?

Ans. NIACL’s 6-session rally unfolded as follows: June 12 (close Rs 152.80) when NSE DRHP filing expectations intensified; June 15 (Rs 160.37, +4.96%); June 16 (Rs 161.76, +0.87%); June 17 (Rs 165.46, +2.29%); June 18 (Rs 178.67) when NIACL surged to an intraday high of Rs 188.50 (+14.24%) as NSE filed the DRHP, before closing at Rs 178.67; and June 19 with an opening of Rs 180, day high of Rs 198.50 and CMP of Rs 196.12 (+9.77%). The cumulative gain from the June 12 close of Rs 152.80 to the current Rs 196.12 is approximately 28%.

What are NIACL’s fundamentals and 52-week range?

Ans. NIACL (The New India Assurance Company Limited) is India’s largest non-life general insurance company. For FY26, NIACL reported gross premium growth of 8.2% and PAT growth of approximately 40-60% year-on-year. Revenue for FY26 was Rs 12,487.6 crore (+13.9% YoY). Market share was 12.74% in the non-life segment, though the combined ratio worsened due to claims and wage revisions. The board declared a dividend of Rs 1.50 per share for FY26. NIACL has a 52-week high of Rs 214.74 and a 52-week low of Rs 116.97. At the current price of Rs 196.12, market cap is approximately Rs 29,444 crore.

What other stocks rallied on the NSE IPO DRHP filing?

Ans. Beyond NIACL (+14.24% on June 18) and IFCI (+4.3% intraday on June 18 before falling sharply), several other NSE-linked stocks rallied: GIC Re, a direct selling shareholder in the NSE OFS, rose 2.37% to Rs 361.90; LIC rose 4.71% to Rs 437.85 on value-unlock hopes (despite not being in the OFS); NSDL (NSE-owned depository) gained approximately 6% to Rs 942; CDSL jumped approximately 8% to Rs 1,396.80; and BSE gained over 2%. Ace investors with NSE holdings, including Radhakishan Damani, Dolly Khanna and Raamdeo Agrawal, also saw indirect value accretion through their NSE investments.

Is now a good time to buy NIACL or IFCI based on the NSE IPO?

Ans. NIACL has risen approximately 28% in 6 sessions, which already prices in significant value unlock from the NSE IPO. The actual value to NIACL depends on the final NSE IPO price at which NIACL monetises its shares, the quantum of NSE shares NIACL holds, and whether the Rs 5 lakh crore NSE IPO valuation is sustained through the listing process. IFCI’s indirect NSE exposure through SHCIL has largely been priced in through the 102% rally from the March low. Both stocks are trading at elevated levels relative to their standalone business fundamentals. Consult a SEBI-registered financial advisor before investing in either stock.



NSE files IPO DRHP
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply